An Anti-Cancer Agent, ALK Inhibitor “Alecensa®,” Approved for the Treatment of ALK Fusion Gene Positive Unresectable, Recurrent / Advanced Non-Small Cell Lung Cancer
Jul 04, 2014
An Anti-Cancer Agent, ALK Inhibitor “Alecensa®,” Approved for the Treatment of ALK Fusion Gene Positive Unresectable, Recurrent / Advanced Non-Small Cell Lung Cancer
An Anti-Cancer Agent, ALK Inhibitor “Alecensa®,” Approved for the Treatment of ALK Fusion Gene Positive Unresectable, Recurrent / Advanced Non-Small Cell Lung Cancer
